Evaluating the cost-benefit profile of CPI stem cell therapy demands a comprehensive perspective. Proponents often highlight the possibility for substantial therapeutic benefits, particularly in diseases where conventional medications have proven limited. However, this is to assess the substantial financial burden associated with CPI stem cell ther